Contrasting evidence has proven that the reduction of SLC4A4 expression can both prohibit and promote cancer cell proliferation and migratory traits in vitro or in immunodeficient contexts, largely depending on the tumor cell type16–20. Here, SLC4A4 is linked to cancer.